APPLICATIONS OF TECHNOLOGY: Nuclear energy or nuclear fuel reprocessing plants Pharmaceutical isotope production Pharmaceutical companies using lanthanide or actinide drugs Chemical industry ADVANTAGES: Highly selective Improved performance and reliability Versatile process Fewer steps ABSTRACT: Berkeley Lab researchers Rebecca Abergel and … [Read more...] about Selective Complexation and Separation of Tetravalent Metal Ions from Other Ions 2017-107
Biotechnology
Thermostable RNA-Guided Endonucleases (GEOCAS9) 2017-117
APPLICATIONS OF TECHNOLOGY: Genome editing Genetic engineering Gene therapy Research tools (e.g., high-throughput screening of gene functions in cell lines and in vivo) Creation of transgenic animal models ADVANTAGES: Functions under different conditions than current CRISPR-Cas9 proteins (e.g, thermostable and enzymatically active in a wide temperature … [Read more...] about Thermostable RNA-Guided Endonucleases (GEOCAS9) 2017-117
Enhancing Nitrogen Fertilizer Efficiency 2016-155
APPLICATIONS OF TECHNOLOGY: Agriculture ADVANTAGES: Reduced nitrogen loss to the atmosphere during fertilization More sustainable and economically profitable agricultural practices Improved agricultural efficiency ABSTRACT: Berkeley Lab’s Hans Carlson and Adam Deutschbauer have developed a technology to facilitate microbial nitrate reduction in nitrogen … [Read more...] about Enhancing Nitrogen Fertilizer Efficiency 2016-155
Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
APPLICATIONS OF TECHNOLOGY: Treatment and prevention of gadolinium deposition in patients undergoing MRIs Treatment for exposure to toxic metals including lead, tin, and cadmium ADVANTAGES: Strong decorporation efficacy High affinity for the toxic elements gadolinium (Gd), lead (Pb), tin (Sn), and cadmium (Cd) ABSTRACT: Researchers at Berkeley Lab have … [Read more...] about Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
Oral Dosage Forms for Actinide Decorporation Agent 2016-079
APPLICATIONS OF TECHNOLOGY: Treatment of radionuclide exposure Treatment or prevention of gadolinium (Gd) deposition from MRIs Treatment for exposure to toxic metals including lead (Pb), tin (Sn), and cadmium (Cd) ADVANTAGES: Administered orally in a variety of dosage forms Ease of clinical use Enables use during emergencies or mass … [Read more...] about Oral Dosage Forms for Actinide Decorporation Agent 2016-079